Dynatronics Co. (NASDAQ:DYNT) has earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.
Brokers have set a 1-year consensus price objective of $7.50 for the company, according to Zacks. Zacks has also given Dynatronics an industry rank of 93 out of 257 based on the ratings given to related companies.
DYNT has been the topic of a number of recent research reports. ValuEngine raised shares of Dynatronics from a “hold” rating to a “buy” rating in a research report on Thursday, August 2nd. TheStreet raised shares of Dynatronics from a “d” rating to a “c-” rating in a research report on Thursday, September 27th. Finally, Zacks Investment Research cut shares of Dynatronics from a “buy” rating to a “hold” rating in a research report on Wednesday, July 25th.
A hedge fund recently bought a new stake in Dynatronics stock. Wells Fargo & Company MN bought a new position in shares of Dynatronics Co. (NASDAQ:DYNT) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 72,996 shares of the medical equipment provider’s stock, valued at approximately $208,000. Wells Fargo & Company MN owned approximately 0.89% of Dynatronics at the end of the most recent quarter. Institutional investors own 11.46% of the company’s stock.
Shares of DYNT stock opened at $2.70 on Wednesday. The company has a market cap of $22.29 million, a price-to-earnings ratio of -6.75 and a beta of 0.09. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.72 and a current ratio of 1.47. Dynatronics has a fifty-two week low of $2.38 and a fifty-two week high of $3.60.
Dynatronics (NASDAQ:DYNT) last announced its quarterly earnings results on Thursday, September 27th. The medical equipment provider reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). Dynatronics had a negative net margin of 2.49% and a negative return on equity of 8.09%. The business had revenue of $16.90 million for the quarter. As a group, equities research analysts anticipate that Dynatronics will post -0.04 earnings per share for the current fiscal year.
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
Featured Article: Reverse Stock Split
Get a free copy of the Zacks research report on Dynatronics (DYNT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.